Representative before the EPO

Company dna pharma concepts gmbh
no operation time available
3 offices
active in Legal Services

Representative before the EPO

Employment test 51 - 200 employees
Company dna dennemeyer
operating since 1962
1233.93
Headquarter in Howald and 13 offices
active in Legal Services, IP Consulting, IP Portfolio Processing, and IP-related Communication Service

We have observed 17 EP applications Karsten Cremer has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after December 07, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12707142

USE OF HGH FOR THE TREATMENT OF SMALL FOR GESTATIONAL AGE INFANTS UNDER TWO YEARS OF AGE

IPC classification:
A61P 43/00, A61K 38/30, A61K 38/27, A61K 38/25
Applicant:
Mor Research Applications Ltd.
Agent:
Karsten Cremer, Pharma Concepts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12762404

MATERIALS AND METHOD FOR TREATING INTERNAL BODY CAVITIES

IPC classification:
A61K 47/38, A61K 47/34, A61K 47/10, A61K 9/00
Agent:
Multiple attorneys, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Agent:
Karsten Cremer, Pharma Concepts GmbH
Status:
EXAMINATION IN PROGRESS
EP12814463

PRODUCTION OF THERMOREVERSIBLE HYDROGELS FOR THERAPEUTIC APPLICATIONS

IPC classification:
C08F 251/00
Agent:
Multiple attorneys, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB
Agent:
Karsten Cremer, Pharma Concepts GmbH
Status:
GRANT OF PATENT INTENDED
EP12750390

LIPOPHILIC DOPAMINE DERIVATIVES AND THEIR USE

IPC classification:
A61K 31/222, A01N 1/02, C07C 233/33, C07C 233/22, A61P 9/10
Applicant:
Novaliq GmbH
Agent:
Karsten Cremer, Pharma Concepts GmbH
Status:
The patent has been granted
EP12183989

Eye wash compositions

IPC classification:
A61K 31/02, A61P 27/02
Applicant:
Novaliq GmbH
Agent:
Karsten Cremer, Pharma Concepts GmbH
Status:
GRANT OF PATENT INTENDED
EP12862614

SILODOSIN INTERMEDIATE AND PREPARATION METHOD THEREFOR

IPC classification:
C07F 7/18, C07F 7/02, C07F 7/00, C07D 209/08, C07D 209/04, C07D 209/02
Agent:
Karsten Cremer, Pharma Concepts GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13700911

STABILISED PROTEIN COMPOSITIONS BASED ON SEMIFLUORINATED ALKANES

IPC classification:
A61K 47/06, A61K 38/28, A61K 9/08
Applicant:
Novaliq GmbH
Agent:
Karsten Cremer, Pharma Concepts GmbH
Status:
PATENT GRANTED
EP12820058

USE OF (1R,5S)-(+)-1-(NAPHTHALEN-2-YL)-3-AZABICYCLO{3.1.0}HEXANE IN THE TREATMENT OF CONDITIONS AFFECTED BY MONOAMINE NEUROTRANSMITTERS

IPC classification:
A61K 31/05, A01N 31/08
Agent:
Karsten Cremer, Pharma Concepts GmbH
Status:
GRANT OF PATENT INTENDED
EP12802484

ORGANIC COMPOUNDS

IPC classification:
A61K 31/454, C07D 401/12, A61P 25/34, A61P 25/28
Agent:
Karsten Cremer, Pharma Concepts GmbH
Status:
PATENT GRANTED
EP13759781

SEMIFLUORINATED ALKANE COMPOSITIONS

IPC classification:
A61K 47/06, A61K 31/232, A61K 9/08, A61K 9/00, A61P 27/02
Applicant:
Novaliq GmbH
Agent:
Karsten Cremer, Pharma Concepts GmbH
Status:
PATENT GRANTED
EP13762802

COMPOSITIONS COMPRISING MIXTURES OF SEMIFLUORINATED ALKANES

IPC classification:
A61K 31/02, A61P 27/00
Applicant:
Novaliq GmbH
Agent:
Karsten Cremer, Pharma Concepts GmbH
Status:
EXAMINATION IN PROGRESS
EP14703341

PHARMACEUTICAL COMPOSITIONS INCORPORATING LOW-DOSE DRUGS

IPC classification:
A61K 36/00, A61K 31/702, A61K 31/137, A61K 9/20
Agent:
Karsten Cremer, Pharma Concepts GmbH
Status:
EXAMINATION REQUESTED
EP14706551

HYGIENIC AND ASEPTIC PIG CLEANING STATION

IPC classification:
F16L 55/46, B08B 9/055, B08B 3/04
Agent:
Karsten Cremer, Pharma Concepts GmbH
Status:
EXAMINATION REQUESTED
EP14768690

ORGANIC COMPOUNDS

IPC classification:
A01N 45/00, C07D 471/04
Agent:
Karsten Cremer, Pharma Concepts GmbH
Status:
EXAMINATION REQUESTED
EP14752171

NOVEL USES

IPC classification:
C07D 487/14, C07D 487/04, A61K 31/519
Agent:
Karsten Cremer, Pharma Concepts GmbH
Status:
GRANT OF PATENT INTENDED
EP14716609

ORAL PHARMACEUTICAL COMPOSITION COMPRISING TASTE-MASKED N-ACETYLCYSTEINE

IPC classification:
A61K 31/198, A61K 9/51, A61K 9/50
Agent:
Karsten Cremer, Pharma Concepts GmbH
Status:
The patent has been granted
EP14765123

ORGANIC COMPOUNDS

IPC classification:
A61K 31/4985
Agent:
Karsten Cremer, Pharma Concepts GmbH
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature